Choate Investment Advisors Reduces Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Choate Investment Advisors decreased its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 21,918 shares of the exchange traded fund’s stock after selling 870 shares during the quarter. Choate Investment Advisors’ holdings in SPDR S&P Biotech ETF were worth $1,974,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in XBI. Golden State Wealth Management LLC purchased a new stake in SPDR S&P Biotech ETF in the fourth quarter worth $29,000. Kohmann Bosshard Financial Services LLC purchased a new stake in SPDR S&P Biotech ETF in the fourth quarter worth $29,000. Avior Wealth Management LLC raised its holdings in SPDR S&P Biotech ETF by 393.6% in the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after purchasing an additional 307 shares in the last quarter. Tidemark LLC raised its holdings in SPDR S&P Biotech ETF by 101.5% in the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after purchasing an additional 199 shares in the last quarter. Finally, Bank of Jackson Hole Trust bought a new position in SPDR S&P Biotech ETF in the fourth quarter worth $43,000.

SPDR S&P Biotech ETF Trading Up 1.3 %

XBI opened at $87.13 on Friday. The stock has a fifty day simple moving average of $90.06 and a two-hundred day simple moving average of $94.82. The company has a market cap of $5.65 billion, a price-to-earnings ratio of 11.47 and a beta of 0.99. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.